Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations [3]

Journal of Investigative Dermatology

Volumn 128, Issue 3, 2008, Pages 732-735

  Zavattaro, Elisa ^a   Azzimonti, Barbara ^a   Mondini, Michele ^a,b   De Andrea, Marco ^a,b   Borgogna, Cinzia ^a   Dell'Oste, Valentina ^a   Ferretti, Massimo ^a   Nicola, Stefania ^a   Cappellano, Giuseppe ^a   Carando, Adriana ^b   Leigheb, Giorgio ^a   Landolfo, Santo ^b   Dianzani, Umberto ^a   Gariglio, Marisa ^a  

^a Amedeo Avogadro University   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; FAS ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 4; INTERLEUKIN 5; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID SUBSTITUTION; CASE REPORT; CYTOKINE PRODUCTION; CYTOPLASM; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER1 GENE; EVER2 GENE; EXON; FEMALE; FOREARM; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HAND; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LETTER; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PAPULE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN BIOPSY; SUN EXPOSURE;

ANTIGENS, CD95; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; PERFORIN;

EID: 39149092678     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701124     Document Type: Letter

References (13)

1. Azzimonti B, Mondini M, De Andrea M, Gioia D, Dianzani U, Mesturini R et al. (2005) CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol 141:1323-5
2. Balkow S, Kersten A, Tran TT, Stehle T, Grosse P, Museteanu C et al. (2001) Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol 75:8781-91
3. Clementi R, Chiocchetti A, Cappellano G, Cerutti E, Ferretti M, Orilieri E et al. (2006) Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function. Blood 108:3079-84
4. Clementi R, Dagna L, Dianzani U, Dupre L, Dianzani I, Ponzoni M et al. (2004) Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. N Engl J Med 351:1419-24
5. de Oliveira WR, Festa Neto C, Rady PL, Tyring SK (2003) Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 17:394-8
6. Dianzani U, Bragardo M, DiFranco D, Alliaudi C, Scagni P, Buonfiglio D et al. (1997) Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood 89:2871-9
7. Dianzani U, Chiocchetti A, Ramenghi U (2003) Role of inherited defects decreasing Fas function in autoimmunity. Life Sci 72:2803-24
8. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ et al. (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-7
9. Notarangelo L, Casanova JL, Fischer A, Puck J, Rosen F, Seger R et al. (2004) Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 114:677-87
10. Orth G (2006) Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 18:362-74
11. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579-81
12. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W (1999) An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 130:591-601
13. Worth A, Thrasher AJ, Gaspar HB (2006) Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol 133:124-40